Tag: Jenny Li
Han Kun, Zhong Lun act on Sino Biopharm’s USD950m LaNova buy
Han Kun and Zhong Lun advised on Sino Biopharm’s USD950m acquisition of cancer drugmaker LaNova Medicines
What’s ahead?
We gathered opinions from legal professionals on their hopes and plans for this year, and what they have done to survive the past tumultuous years











